FTD, the second most common dementia type after AD, also involves neuroinflammation, evidenced by elevated TNF-α and Transforming growth factor beta (TGF-β) levels in cerebrospinal fluid and increased microglial activation. The gene discussed is TNF; the disease is Alzheimer disease.